| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.084 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |